Tofacitinib therapy for children with severe alopecia areata

J Am Acad Dermatol. 2019 Apr;80(4):1164-1166. doi: 10.1016/j.jaad.2018.12.041. Epub 2019 Jan 8.

Authors

Ying-Xiu Dai¹, Chih-Chiang Chen²

Affiliations

¹ Department of Dermatology, Taipei Veterans General Hospital, Taipei, Taiwan; Department of Dermatology, National Yang-Ming University, Taipei, Taiwan.
² Department of Dermatology, Taipei Veterans General Hospital, Taipei, Taiwan; Department of Dermatology, National Yang-Ming University, Taipei, Taiwan; Institute of Clinical Medicine, National Yang-Ming University, Taipei, Taiwan. Electronic address: docs1.tw@yahoo.com.tw.

PMID: 30630026
DOI: 10.1016/j.jaad.2018.12.041

No abstract available

Publication types

Letter

MeSH terms

Alopecia / drug therapy*
Alopecia Areata / drug therapy*
Child, Preschool
Female
Humans
Male
Piperidines / administration & dosage
Piperidines / therapeutic use*
Protein Kinase Inhibitors / administration & dosage
Protein Kinase Inhibitors / therapeutic use*
Pyrimidines / administration & dosage
Pyrimidines / therapeutic use*
Pyrroles / administration & dosage
Pyrroles / therapeutic use*
Severity of Illness Index

Substances

Piperidines
Protein Kinase Inhibitors
Pyrimidines
Pyrroles
tofacitinib

Supplementary concepts

Alopecia universalis